Archive | Resident Company News

Exact Sciences

FDA committee recommends approval of Exact Sciences’ Cologuard

Exact Sciences Corp. announced that the U.S. Food and Drug Administration’s (FDA) Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee determined by a unanimous vote that Exact Sciences has demonstrated safety, effectiveness and a favorable risk benefit profile of Cologuard ®, the company’s stool-based DNA (sDNA), non-invasive colorectal cancer screening test. Read […]

Continue Reading

Stemina marks big advance with EPA contract

A $10.6 million, five-year EPA contract for Stemina Biomarker Discovery, announced this week, doesn’t just provide a new source of revenue. It also holds the potential to make the Madison company’s technology a standard for testing chemicals and drugs for their toxic effects, long-term, CEO Elizabeth Donley said.Read more

Continue Reading

BMG LABTECH and InvivoSciences, Inc. Initiate Market Collaboration To Accelerate Drug Discovery in Engineered 3D Tissues

Cary, NC – November 17, 2013. BMG LABTECH, Inc. – the Microplate Reader Company – and InvivoSciences, Inc. – a leader in stem cell tissue engineering providing a novel solution in first-in-class drug discovery – announced today a strategic collaboration to market the time-dependent fluorescent assessment of engineered 3D heart tissues using advanced microplate reader […]

Continue Reading

NCD Technologies Officially Recognized on R&D Magazine’s 100 Awards List for 2013

NCD Technologies, a rising star in nano technologies, is proud to announce that their Nanocrystalline Diamond Pretreatment (NDP) an innovative and unprecedented process for applying diamond coatings to extremely small tooling, has been selected by R&D Magazine’s 100 list for technological excellence. NCD Technologies’ coatings are the result of a state-of-the-art pretreatment process for applying […]

Continue Reading

Stratatech (private) awarded BARDA contract valued up to $47.2 M

For Advanced Development of StrataGraft® Skin Tissue for Thermal Burns Stratatech Corp has been awarded a contract valued at up to $47.2 M by the U.S. Department of Health and Human Service’s Biomedical Advanced Research and Development Authority (BARDA). The contract is for the advanced clinical and manufacturing development of StrataGraft® skin tissue, its skin […]

Continue Reading

Facebook IconYouTube IconTwitter IconVisit Our LinkedIn Profile